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Abstract The DNA-dependent adenosine triphosphatase
(ATPase) Plk1-interacting checkpoint helicase (PICH) has
recently been implicated in spindle checkpoint (SAC)
signaling (Baumann et al., Cell 128(1):101–114, 2007).
Depletion of PICH by siRNA abolished the SAC and
resulted in an apparently selective loss of Mad2 from
kinetochores, suggesting a role for PICH in the regulation
of the Mad1–Mad2 interaction. An apparent rescue of SAC
functionality by overexpression of PICH in PICH-depleted
cells initially seemed to confirm a role for PICH in the
SAC. However, we have subsequently discovered that all
PICH-directed siRNA oligonucleotides that abolish the
SAC also reduce Mad2 mRNA and protein expression.
This reduction is functionally significant, as PICH siRNA
does not abolish SAC activity in a cell line that harbors a
bacterial artificial chromosome driving the expression of
murine Mad2. Moreover, we identified several siRNA
duplexes that effectively deplete PICH but do not signifi-
cantly affect SAC functionality or Mad2 abundance or
localization. Finally, we discovered that the ability of
overexpressed PICH to restore SAC activity in PICH-
depleted cells depends on sequestration of the mitotic
kinase Plk1 rather than ATPase activity of PICH, pointing
to an underlying mechanism of “bypass suppression.” In
support of this view, depletion or inhibition of Plk1 also
rescued SAC activity in cells harboring low levels of Mad2.
This observation suggests that a reduction of Plk1 activity
partially compensates for reduced Mad2 levels and argues
that Plk1 normally reduces the strength of SAC signaling.
Collectively, our results question the role of PICH in the
SAC and instead identify Mad2 as a sensitive off target for
small RNA duplexes. In support of the latter conclusion,
our evidence suggests that an off-target effect on Mad2 may
also contribute to explain the apparent role of the Tao1
kinase in SAC signaling (Draviam et al., Nat Cell Biol 9
(5):556–564, 2007).
Introduction
The DNA-dependent adenosine triphosphatase (ATPase)
Plk1-interacting checkpoint helicase (PICH) was discov-
ered as a binding partner and substrate of the mitotic kinase
Plk1 (Baumann et al. 2007). During early mitosis, PICH is
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mitotic chromosomes. In response to inhibition or depletion
of Plk1, PICH spreads over chromosome arms, indicating
that its localization is controlled by Plk1 activity (Baumann
et al. 2007). Conversely, PICH apparently contributes to the
recruitment of Plk1 to chromosome arms (Santamaria et al.
2007; Leng et al. 2008). Most interestingly, PICH asso-
ciates with ultrafine DNA bridges (UFBs) that often
connect the KTs of separating sister chromatids (Baumann
et al. 2007; Wang et al. 2008). After inactivation of the
SAC and cleavage of centromere-associated cohesin com-
plexes by separase (Hauf et al. 2001; Uhlmann et al. 1999),
PICH-positive UFBs elongate concomitant with sister
chromatid separation and often reach lengths of several
microns before they are finally resolved, presumably
through the action of topoisomerase II (Baumann et al.
2007; Wang et al. 2008). While PICH presently constitutes
the most universal marker for UFBs, it is intriguing that
Bloom syndrome RecQ helicase as well as its complex
partners RMI1 and topoisomerase III also associate with
some PICH-positive structures (Chan et al. 2007; Bachrati
and Hickson 2008). Moreover, a subset of noncentromeric
UFBs was recently found to connect fragile site loci
associated with Fanconi anemia proteins FANCD2 and
FANCI, and the available evidence suggests that these latter
UFBs reflect abnormal intertwined DNA structures induced
by replicative stress (Chan et al. 2009; Naim and Rosselli
2009).
The conspicuous localization of PICH to the centromere/
KT region originally suggested a role for this DNA-
dependent ATPase in the SAC. In support of this idea,
siRNA-mediated depletion of PICH by two different siRNA
oligonucleotides (PICH-1 and PICH-2) abolished the
checkpoint (Baumann et al. 2007), and results consistent
with SAC failure were subsequently observed after deple-
tion of PICH by a third siRNA oligonucleotide (hereafter
referred to as PICH-CC; Leng et al. 2008). Furthermore,
siRNA-mediated PICH depletion caused the apparently
selective loss of the checkpoint protein Mad2 from KTs,
while the localization of the Mad2-binding partner Mad1
was unaffected (Baumann et al. 2007). Independently, an
apparently selective loss of Mad2 from KTs was reported in
response to siRNA-mediated depletion of the protein kinase
Tao1, whose apparent role in the SAC was discovered in a
functional genomic screen (Draviam et al. 2007). At face
value, these observations suggested that both PICH and
Tao1 are required for SAC activity and that these two
proteins might cooperate in regulating the Mad1–Mad2
interaction at KTs.
The present study was undertaken with the aim of
elucidating the molecular mechanism underlying the pur-
ported checkpoint function of PICH. Although this function
appeared to be supported by concordant results obtained
with three different siRNA oligonucleotides, the studies
described here lead us to conclude that the checkpoint
failure formerly attributed to the depletion of PICH most
likely reflects an off-target effect that causes the lowering of
Mad2 transcript and protein. Our data further suggest that
an off-target effect may similarly explain the purported
checkpoint function of the Tao1 kinase. The direct (off)
target of the various siRNA oligonucleotides examined here
is unlikely to be the Mad2 transcript itself; instead, our
results suggest that the regulatory network controlling
Mad2 expression represents a particularly sensitive target
for small RNAs. Interestingly, the off-target effect of a
PICH-directed siRNA oligonucleotide could be rescued by
overexpression of PICH, which a priori would seem to
demonstrate specificity. However, we discovered that this
apparent rescue required the ability of the overexpressed
protein to sequester the mitotic kinase Plk1. A similar,
albeit partial “rescue” could be accomplished by depletion
or inhibition of Plk1, thus providing an example for the
apparent “rescue” of a siRNA phenotype via bypass
suppression.
Results and discussion
Re-examination of the proposed SAC function of PICH
PICH could effectively be depleted from HeLa cells using
any one of three different siRNA oligonucleotides, referred
to as PICH-1, PICH-2, and PICH-CC. Live-cell imaging
performed on HeLa cells stably expressing histone H2B–
green fluorescent protein (GFP) showed that all three
siRNA treatments also caused remarkably similar mitotic
phenotypes. Compared to control siRNA (siGL2)-treated
cells, PICH-depleted cells failed to form proper metaphase
plates and instead displayed premature onset of anaphase
(Supplementary Fig. 1a); moreover, PICH-depleted cells
failed to arrest in response to nocodazole (Supplementary
Fig. 1b), confirming and extending previous results
(Baumann et al. 2007). To strengthen the conclusion that
PICH is the critical target of siRNA in these experiments,
we asked whether normal mitotic timing could be restored
in PICH-1 siRNA-treated cells by overexpression of an
siRNA-resistant PICH protein tagged with mCherry.
Whereas control cells spent an average time of 43.8 min
between nuclear envelope breakdown (NEBD) and ana-
phase onset, PICH-depleted cells expressing mCherry
vector alone expeditiously initiated anaphase with an
average time of 26.8 min (Fig. 1). In contrast, the
overexpression of mCherry-tagged PICH wild type (WT)
successfully restored the mitotic timing to near-normal
levels (42.6 min), although some cells died, in line with the
previously observed toxicity of excess PICH (Fig. 1;
150 Chromosoma (2010) 119:149–165Baumann et al. 2007). The concordant phenotypes pro-
duced by three independent siRNA oligonucleotides and
the apparently successful rescue initially bolstered our
confidence that PICH plays an essential role in SAC
signaling. However, several observations subsequently
challenged this conclusion, as described in the following
sections.
A first unexpected result emerged when we generated a
293T cell line (293T TREX-shPICH), which allowed the
inducible expression of a short hairpin RNA (shRNA)
coding for the PICH-1 siRNA sequence. Three stable
clones were obtained, all of which showed efficient PICH
depletion after 72 h of incubation with tetracycline. This
depletion was reversible, as PICH protein was partially
restored upon removal of tetracycline and incubation of
cells in tetracycline-free medium for 72 h (Fig. 2a). Much
to our surprise, none of these three 293T cell lines showed
any sign of SAC failure (such as aberrant mitoses or
micronucleation; data not shown), although PICH was
efficiently depleted (Fig. 2a, b). Furthermore, neither the
KT localization of Mad2 nor its levels were detectably
affected upon PICH depletion (Fig. 2a, c). Taken at face
value, these results suggested the existence of cell-type-
specific differences in the response of HeLa and 293T cells
to PICH depletion, challenging the idea that PICH is an
essential component of the SAC in all cell types.
A second disturbing result emerged when we tried to
restore SAC activity in PICH-depleted HeLa cells by re-
expressing PICH protein at physiological levels. Specifi-
cally, we examined the consequences of depleting PICH
from a HeLa cell line stably expressing a LAP-tagged
mouse homolog of PICH (Poser et al. 2008; Wang et al.,
manuscript submitted). Although mouse PICH (Ercc6L)
shares extensive sequence similarity with its human
ortholog (72% amino acid identity; 81% amino acid
similarity), expression of LAP-mouse PICH failed to
restore SAC functionality in PICH-1 siRNA-treated HeLa
cells, as indicated by both extensive micronucleation
(Fig. 3a) and accelerated mitosis (Fig. 3b). Yet, LAP-
mouse PICH was clearly resistant to PICH-1 siRNA
treatment; in fact, LAP-mouse PICH showed enhanced
expression upon depletion of endogenous human PICH,
suggesting the existence of a feedback mechanism control-
ling total PICH protein levels (Fig. 3c). These results
suggested that either mouse PICH is not able to provide
SAC functionality in human cells, that LAP tagging
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Fig. 1 Overexpression of PICH in PICH siRNA-treated cells restores
mitotic timing. HeLa cells stably expressing histone H2B-GFP were
transfected simultaneously with the indicated siRNA duplexes and
plasmids and analyzed by time-lapse microscopy. mCherry-positive
cells were analyzed to determine the average time from NEBD to
anaphase onset. Left panels show single-plane images selected from
movies, and time stamps indicate hours:minutes. Right panels show
representative fate maps of 25 individual cells (the whole experiment
being repeated independently three times), with red columns indicat-
ing the time span from NEBD to anaphase onset and blue columns
indicating cells that died in interphase during imaging. Average times
from NEBD to anaphase onset are indicated to the right
Chromosoma (2010) 119:149–165 151interfered with functionality, or that PICH is not the only
target of PICH-1 siRNA.
Although earlier observations had suggested that PICH
depletion affected Mad2 localization to KTs rather than
Mad2 protein levels (Baumann et al. 2007), in the course of
the above studies, we noticed that treatment of HeLa cells
with the siPICH-1 oligonucleotide caused a reduction in the
levelofMad2protein(Fig.3a). Thus, the expression of Mad2
protein in response to various PICH siRNA treatments was
carefully re-examined. Remarkably, depletion of PICH by all
three published PICH-directed siRNAs showed detectable,
albeit partial, reduction of Mad2 protein levels (Fig. 4a).
Virtually identical results were obtained regardless of
whether cells were arrested by thymidine or collected by
shake off from an MG132-arrest (data not shown), demon-
strating that the observed decrease in Mad2 protein was
independent of cell cycle stage. Transfection of cells with
siRNAs targeting several genuine SAC components did not
cause a reduction of Mad2 protein (Fig. 4b). This rules out
general effects related to siRNA transfection per se and
demonstrates that the observed reduction of Mad2 levels in
PICH siRNA-treated cells is not simply a consequence of
SAC abrogation.
If the previously observed loss of Mad2 protein from
KTs in PICH-depleted cells reflected a depletion of Mad2
protein rather than a selective disruption of the Mad1–
Mad2 interaction at KTs, we reasoned that it might be
possible to restore Mad2 localization to KTs by over-
expression of exogenous Mad2 protein in PICH siRNA-
treated cells. This was indeed the case, as a Mad2–GFP
fusion protein readily localized to KTs in a PICH-1 siRNA
background (Supplementary Fig. 2a). In contrast, overex-
pressed Mad2–GFP did not localize to KTs in cells depleted
of Aurora B (Supplementary Fig. 2b), consistent with
previous reports (Ditchfield et al. 2003; Vigneron et al.
2004). These observations thus support the conclusion that
the PICH siRNA phenotype reported previously might
reflect a change in Mad2 abundance rather than localization.
To investigate the mechanism underlying the reduction
in Mad2 protein, we next asked whether this reduction was
also reflected at the mRNA level. To this end, PICH, Mad1,
and Mad2 mRNAs were measured by quantitative real-time
polymerase chain reaction (qRT-PCR) in HeLa cells
depleted of either PICH or Mad1 for control. As summa-
rized in Fig. 4c, all three PICH siRNAs displayed almost
identical knockdown efficiencies with regard to PICH
mRNA. Remarkably, all three PICH siRNAs also caused
a significant decrease of Mad2 mRNA when compared to
the siGL2 control, whereas Mad1 mRNA was not detect-
ably affected (Fig. 4c). As expected, Mad1 siRNA depleted
Mad1 mRNA but did not reduce either PICH or Mad2
mRNA (Fig. 4c). Taken together, these results suggest that
treatment of HeLa cells with any one of the three
previously published PICH siRNA oligonucleotides
reduces not only PICH but also Mad2 mRNA levels,
suggesting that the previously observed loss of checkpoint
functionality might actually reflect a reduction, albeit
partial, of cellular Mad2 protein. This in turn implies that
either PICH protein somehow regulates Mad2 expression
or, alternatively, that the three PICH-directed siRNA
oligonucleotides all display off-target effects that cause a
lowering of Mad2 expression.
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Fig. 2 PICH is not essential for SAC activity in 293T TREX cells.
After selection of three different clones (nos. 12, 30, 32) of 293T
TREX cells allowing the inducible expression of a PICH-directed
shRNA (modeled after PICH-1 siRNA), PICH levels were monitored
by Western blotting. In parallel, KT localization of PICH and Mad2
was examined by immunofluorescence microscopy. a Three different
clones (12, 30, and 32) of stably transfected 293T TREX-shPICH cells
were analyzed by Western blotting for the expression of PICH and
Mad2; α-Tubulin was monitored as a loading control. b Bar graph
shows quantitative analysis of PICH localization to KTs before and
after 72 h tetracycline induction (n>100). c Bar graph shows
quantitative analysis of Mad2 localization to KTs before and after
72 h tetracycline induction (n>100)
152 Chromosoma (2010) 119:149–165To distinguish between these possibilities, we sought to
identify novel siRNA oligonucleotides that would effec-
tively deplete PICH without lowering Mad2 mRNA and
protein levels. Indeed, four new siRNAs, referred to as
PICH-3, PICH-4, PICH-5, and PICH-6, as well as a
corresponding pool (PICH-SP; comprising all four
duplexes), were found to deplete PICH effectively. In a
direct comparison, PICH-3, PICH-4, and PICH-5 showed
comparable efficiency to PICH-1, PICH-2, and PICH-CC
siRNA, whereas PICH-6 and the pooled PICH-SP duplexes
were slightly less efficient (Fig. 5a). Similar results were
obtained regardless of the duration of treatment, indicating
that the kinetics of depletion were also comparable
(Supplementary Fig. 3). Most importantly and in striking
contrast to PICH-1, PICH-2, and PICH-CC, none of the
new PICH-directed siRNA oligonucleotides detectably
affected Mad2 expression, regardless of whether Mad2
protein (Fig. 5a) or mRNA (Fig. 5b) was monitored.
Furthermore, none of the new oligonucleotides detectably
interfered with KT localization of Mad2, in contrast to cells
treated with PICH-1, PICH-2, and PICH-CC siRNA
(Fig. 5c, d). Most importantly, we also examined the
influence of the new PICH-directed oligonucleotides on
both nocodazole-induced SAC activation (Fig. 5e, f) and
the timing of mitotic progression (Fig. 5g). In addition to
determining the mitotic index after nocodazole treatment
(Fig. 5e), live-cell imaging was performed on HeLa cells
stably expressing histone H2B–GFP (Fig. 5f, g). Both
mitotic timing (NEBD to anaphase onset) and the duration
of the nocodazole-induced SAC arrest were very similar in
cells treated with the new PICH-directed siRNAs and in
GL2-treated controls, in striking contrast to cells treated
with the previously described PICH siRNA oligonucleo-
tides, which advanced anaphase onset and abolished SAC
activity (Fig. 5f, g). In our view, the most plausible
interpretation of these results is that the originally described
PICH-directed siRNA duplexes interfere with SAC activity
because they lower Mad2 transcript and protein levels
through an off-target effect. We recognize, however, that in
principle one could also attribute an off-target effect to
those siRNA duplexes that do not lower Mad2 expression.
In particular, one could argue that PICH plays a physio-
logical role in controlling Mad2 expression and that the
failure of some duplexes to affect Mad2 levels (and hence
checkpoint functionality) might reflect off-target effects
interfering with this (hypothetical) regulation. A genetic
PICH knockout will be required to formally exclude this
alternative interpretation.
Re-examination of the role of Tao1 kinase in the spindle
checkpoint
Recently, a genome-wide siRNA screen identified a
requirement for the Tao1 kinase (also known as microtu-
bule affinity-regulation kinase kinase (MARKK); Johne et
al. 2008; Timm et al. 2003) in the spindle checkpoint
(Draviam et al. 2007). Moreover, Tao1 depletion was
reported to cause a selective loss of Mad2 but not Mad1
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Chromosoma (2010) 119:149–165 153from KTs (Draviam et al. 2007), highly reminiscent of the
early data obtained after PICH siRNA (Baumann et al.
2007). Intrigued by this similarity, we originally suspected
that PICH and Tao1 cooperate in a regulatory step
controlling Mad2 localization. However, having obtained
evidence that the apparent requirement for PICH in Mad2
localization is likely to reflect an off-target effect, we
wondered whether a similar explanation might pertain to
Tao1. To explore this possibility, we compared different
Tao1-directed siRNA oligonucleotides for their efficiency
to deplete Tao1, their effects on Mad2 localization, protein,
and transcript levels, as well as their ability to abolish SAC
activity. This survey included the most effective previously
published Tao1 siRNA oligonucleotide (Tao1-NCB3) as
well four new oligonucleotides (Tao1-2 to Tao1-5) and a
smart pool comprising Tao1-2 to Tao1-5 (Tao1-SP).
All Tao1-directed siRNAs exhibited a similar ability to
deplete Tao1 from HeLa cells, and curiously, PICH-1
siRNA also lowered Tao1 levels (Fig. 6a). Most impor-
tantly, siTao1-NCB3 additionally caused a significant
reduction of Mad2 protein, comparable to the reduction of
Mad2 seen after PICH-1 or PICH-CC siRNA (Fig. 6a). We
cannot presently explain the discrepancy between this
observation and the previous report, indicating that Tao1
siRNA does not lower Mad2 levels (Draviam et al. 2007).
In any case, however, Mad2 levels remained unaffected
upon treatment of cells with the other Tao1 siRNAs, except
for Tao1-4, which produced a marginal effect (Fig. 6a).
Similar results were also obtained upon depletion of Tao1
from U2OS and RPE-1 cells (Supplementary Fig. 4a, b).
Quantitative Western blot analysis (three independent
experiments; normalized to α-Tubulin) revealed that
Tao1-NCB3 siRNA lowered Mad2 protein levels substan-
tially, whereas the other Tao1-directed siRNAs barely
affected Mad2, although they depleted Tao1 with similar
efficiency as Tao1-NCB3 (Fig. 6b). In line with these
observations, the KT localization of Mad2 was abolished
only in cells treated with the Tao1-NCB3 siRNA but not in
cells treated by any of the other Tao1-directed siRNAs
(Fig. 6c, d).
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Chromosoma (2010) 119:149–165 155Next, we used qRT-PCR to analyze the mRNA levels of
Mad1, Mad2, and Tao1 after treatment of HeLa cells with
different siRNAs targeting Tao1 or PICH. While Mad1
mRNA remained constant in all cases, Tao1 mRNA levels
were similarly reduced by all Tao1 siRNAs and, to a lesser
extent, PICH-1 siRNA (Fig. 7a). Most importantly, Mad2
mRNA was significantly reduced upon treatment with
siPICH-1 and siTao1-NCB3 siRNAs and, to a lesser extent,
Tao1-4 siRNA. No changes in Mad2 mRNA levels were
detectable in cells treated with siPICH-3, siTao1-2, siTao1-
3, or control siRNA (siGL2; Fig. 7a). Parallel investigation
of cellular phenotypes by time-lapse microscopy (Fig. 7b)
revealed that cells depleted of Tao1 by Tao1-NCB3 siRNA
went through mitosis more rapidly (NEBD to anaphase;
average 14 min) than control cells (average 33 min).
Mitotic timing was also reduced in cells treated with the
Tao1-4 siRNA, albeit to a lesser extent (average 23 min),
but not in response to any of the other Tao1-directed siRNA
duplexes (Fig. 7b). Similarly, in line with the original report
implicating Tao1 in SAC function (Draviam et al. 2007), an
override of the nocodazole-induced SAC arrest could be
observed in response to siTao1-NCB3 (average duration of
arrest 25 min), whereas a robust checkpoint arrest (often
followed by cell death after 12–15 h) was seen upon
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Fig. 6 Evaluation of protein knockdown efficiency, Mad2 localiza-
tion, and SAC phenotype for different siRNA oligonucleotides
targeting Tao1 kinase. a HeLa cells were transfected with the indicated
siRNA duplexes, and lysates were probed by Western blotting with
the indicated antibodies. Asterisks indicate the reduction of Mad2
levels by some but not all Tao1 and PICH-directed siRNAs. b Three
independent experiments were performed as in a, and Western blots
were used for quantification of Mad2 and Tao1 protein levels. Band
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The histograms show the mean band intensities normalized against
background and α-Tubulin, and error bars indicate standard errors.
Note that Mad2 protein levels were significantly reduced in lysates
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by asterisks). c Cells were treated with different Tao1-directed siRNAs
and stained with antibodies directed against Mad2 (red); DNA was
stained with DAPI (blue). Scale bar indicates 5 µm. Note that Mad2 is
displaced from KTs only in response to Tao1-NCB3, but not other
Tao1-directed duplexes. d Quantitative analysis of Mad2 localization
in cells depleted of Tao1. HeLa cells were treated as described in c.
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156 Chromosoma (2010) 119:149–165depletion of Tao1 by siTao1-2 or siTao1-3 (Fig. 7c). Cells
treated with Tao1-4 siRNA showed a partial phenotype in
that they usually exited mitosis after about 4 h (Fig. 7c).
Collectively, we interpret the above data to suggest that the
apparent role of the Tao1 kinase in SAC signaling might in
reality reflect an off-target effect produced by particular
Tao1-directed siRNA oligonucleotides on Mad2, similar to
the situation described above for certain PICH siRNA
duplexes.
Rescue of PICH and Tao1 siRNA phenotypes by Mad2
expression from a bacterial artificial chromosome
If, as argued above, the abrogation of the SAC in cells
treated by some PICH- and Tao1-directed siRNA oligonu-
cleotides were reflecting an off-target effect that causes a
reduction of Mad2 levels, it should in principle be possible
to rescue this phenotype by re-expressing Mad2. To test this
prediction, we used bacterial artificial chromosome trans-
genesis which is expected to restore protein expression to
near physiological levels (Poser et al. 2008). Specifically, a
pool of HeLa cells expressing a LAP-tagged murine Mad2
was subjected to PICH, Tao1, and Mad2 siRNA, and SAC
functionality was then examined by live-cell imaging
(Fig. 8a). In these experiments, GFP-positive cells (express-
ing murine Mad2) could directly be compared to GFP-
negative cells (devoid of murine Mad2). In parallel, the
levels of PICH, Tao1, human Mad2, and murine Mad2
were monitored by Western blotting (Fig. 8b). As expected,
the mitotic timing (NEBD to anaphase onset) was acceler-
ated in GFP-negative cells subjected to PICH-1, Tao1-
NCB3, or Mad2 siRNA, when compared to GL2 controls.
In contrast, mitotic timing was similar in GFP-positive
cells, regardless of whether they were treated with GL2
control or Mad2 siRNA, attesting to the ability of murine
Mad2 to compensate for the depletion of endogenous
human Mad2. In the case of PICH siRNA, GFP-positive
cells showed a delay in the traverse of mitosis, suggesting
that loss of PICH in cells harboring (near) physiological
levels of Mad2 actually triggers a mitotic delay. GFP-
positive Tao1 siRNA-treated cells also showed a slowing of
mitotic traverse compared to GFP-negative cells, although
passage through mitosis was still faster than in GL2-treated
controls. Taken at face value, this would be consistent with
the notion that Tao1 is required for full SAC functionality
even in the presence of physiological levels of Mad2
(Draviam et al. 2007). However, we note that all GFP-
positive, murine Mad2-expressing cells showed a pro-
longed arrest in response to nocodazole, regardless of
whether they were treated with PICH, Tao1, or (human)
Mad2 siRNA (data not shown). Collectively, these data
make a strong case that the observed reduction of Mad2
levels is largely, although in the case of Tao1 perhaps not
exclusively, responsible for the abrogation of SAC activity
in the PICH- and Tao1-siRNA-treated cells.
Uncovering of a regulatory influence of Plk1 on Mad2
function
A critical role for PICH and Tao1 in the SAC had originally
been supported not only by consistent siRNA phenotypes
but also apparently successful rescue experiments (this
study, Fig. 1; Draviam et al. 2007). In particular, the SAC
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Chromosoma (2010) 119:149–165 157abrogation produced by Tao1-NCB3 siRNA could success-
fully be rescued by active but not inactive kinase, strongly
supporting a role for Tao1 in the SAC (Draviam et al.
2007). However, the published evidence suggests that this
rescue involved overexpression of siRNA-resistant Tao1
(Draviam et al. 2007), raising the possibility of a “bypass
suppression” (in genetic terms) rather than a genuine
rescue. In particular, we consider it possible that excess
exogenous Tao1 activity might have interfered with
chromosome attachment to the spindle apparatus in such a
way that even reduced levels of Mad2 might have been
sufficient to restore an SAC response. So it would seem
critical to demonstrate restoration of SAC activity in Tao1-
depleted cells by physiological levels of Tao1 kinase.In the
case of PICH, our results clearly demonstrate that over-
expression of PICH protein restored SAC functionality in
PICH-1 siRNA-treated cells (Fig. 1), and yet, physiological
levels of LAP-mouse PICH provided no rescue (Fig. 3b). A
first clue for how to explain this discrepancy emerged when
we tested two PICH mutants for their ability to restore
normal mitotic timing in PICH-1 siRNA-treated cells. In
fact, a PICH protein carrying a mutation predicted to
abolish its ATPase activity (K128A, Wang et al., submitted;
Leng et al. 2008) readily restored SAC activity in PICH-1
siRNA-treated cells, whereas a mutant that cannot bind
Plk1, due to a mutation within the so-called Polo-box
domain (T1063A), failed to restore proper mitotic timing
(Fig. 9a). These unexpected results could not be attributed
to different expression levels of the rescuing constructs, as
neither the transfection efficiencies nor the levels of
overexpression achieved revealed significant differences
(Fig. 9b). Instead, they demonstrate that restoration of SAC
functionality in PICH-1 siRNA-treated cells depends on the
ability of the overexpressed PICH protein to sequester Plk1,
rather than its ATPase activity. One straightforward inter-
pretation of this result is that residual Mad2 protein, as it
persists after PICH-1 siRNA, was sufficient to provide SAC
activity, provided that Plk1 was sequestered by exogenous
wild-type or ATPase-deficient PICH protein. Thus, the
observed restoration of SAC activity would represent a case
of bypass suppression rather than genuine rescue.
A corollary of the above interpretation is that Plk1
activity contributes to regulate the efficacy of Mad2 in SAC
signaling, so that less Mad2 is needed for SAC function-
ality in the absence of Plk1 than in its presence. If this were
the case, one would predict that siRNA-mediated depletion
of Plk1 or inhibition of Plk1 by the small molecule inhibitor
TAL (Santamaria et al. 2007) should also be able to restore
SAC activity in PICH-1 siRNA-treated cells. To directly
test this prediction, we performed live-cell imaging on
HeLa cells stably expressing histone H2B–GFP and
monitored mitotic progression under various treatments.
Cells were depleted of either PICH or Tao1, using PICH-1
or Tao1-NCB3 siRNA, respectively, and some samples
were subjected to additional depletion of Plk1 by siRNA or
treated with TAL. Whereas cells treated with PICH-1
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158 Chromosoma (2010) 119:149–165siRNA alone showed no mitotic arrest in response to
nocodazole (Fig. 5f), codepletion of Plk1 or inhibition of
Plk1 by TAL resulted in mitotic delays of 120 and 160 min,
respectively (Fig. 10a), before cells exited mitosis without
chromosome segregation and often formed micronuclei
(data not shown). Single depletion of Plk1 or inhibition of
Plk1 caused a prolonged prometaphase delay, mostly
followed by apoptosis (Fig. 10a), as expected (Santamaria
et al. 2007; Liu and Erikson 2003; Petronczki et al. 2008).
We also analyzed the effect of Plk1 depletion or
inhibition on cells that were treated with Tao1-NCB3
siRNA (Fig. 10b). Whereas control cells exhibited the
expected mitotic timing, Tao1-NCB3 siRNA-treated cells
separated their chromosomes in less than 20 min without
forming a metaphase plate. The simultaneous depletion of
Plk1 by siRNA or its inhibition by TAL increased the
timing in Tao1-NCB3 siRNA-treated cells to about 35 min,
similar to the duration seen in control cells but far below
the duration of the mitotic arrest seen after depletion of
Plk1 alone (Fig. 10b). This suggests that Plk1 depletion or
inhibition only marginally restored SAC activity in Tao1-
NCB3 siRNA-treated cells, presumably because residual
Mad2 levels were too low (see below).
To demonstrate that residual Mad2 was critical for the
restoration of SAC activity by Plk1 depletion/inhibition in
PICH-1 or Tao1-NCB3 siRNA-treated cells, we also
b
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onset are indicated to the right. b Quantification of overexpression of
mCherry-PICH WT, mCherry-PICH K128A, and mCherry-PICH
T1063A in comparison to endogenous PICH. HeLa cells were
transfected with the indicated plasmids as in a, and total cell lysates
were subjected to serial dilutions before Western blotting with anti-
PICH antibody. Transfection efficiency (indicated to the right) was
determined by immunofluorescence staining using anti-mCherry
antibody, and fold overexpression was calculated, taking into account
the dilution factor and the transfection efficiency. This experiment
indicates that the mCherry-PICH constructs were similarly overex-
pressed (about 20–24-fold) when compared to endogenous PICH
levels
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Fig. 10 Codepletion of PICH and Plk1 restores SAC activity. a–c
HeLa cells stably expressing H2B-GFP were subjected to single and
double depletion (PICH, Tao1, Mad2, Plk1) or inhibition (Plk1)
experiments, as described in each panel, and analyzed by time-lapse
microscopy. Histograms illustrate the mitotic timing from NEBD to
mitotic exit or cell death. Error bars represent standard error (n=40).
d Western blot analysis of Mad2 abundance after transfection of HeLa
cells with increasing concentrations of Mad2 siRNA duplex (0.06, 1.2,
3.2, 6.6, 20 pM) and PICH-1, Tao1-NCB3, and GL2 siRNA for
comparison. α-Tubulin serves as loading control. e HeLa cells stably
expressing H2B-GFP were transfected with increasing amounts of
Mad2 siRNA (as described in d) as well as PICH-1 and Tao1-NCB3
duplexes, prior to synchronization with thymidine and release into
1 µM TAL-containing medium. Then, the mitotic timing from NEBD
to anaphase onset was determined by live-cell imaging. Histograms
illustrate the results from three independent experiments (n=20 for
each experiment), and error bars represent standard error
160 Chromosoma (2010) 119:149–165examined the consequences of combining Plk1 inhibition
with direct siRNA-mediated depletion of Mad2. As shown
in Fig. 10c, TAL addition could not restore normal mitotic
timing to cells that were extensively depleted of Mad2,
arguing that the absence of Plk1 activity cannot rescue SAC
functionality in cells from which the bulk of Mad2 has been
depleted. These results support the view that residual Mad2,
as it persists after PICH-1 or Tao1-NCB3 siRNA treatment,
is critical for the restoration of some SAC activity upon
depletion or inhibition of Plk1. As a final test of this
conclusion, different amounts of Mad2 siRNA oligonucleo-
tides were used to reduce cellular Mad2 to levels within the
range of those seen as a consequence of PICH-1 or Tao1-
NCB3 siRNA treatment (Fig. 10d). Then, live-cell imaging
was used to analyze mitotic timing in TAL-treated cells as a
function of Mad2 levels. As shown in Fig. 10e, the mitotic
timing (NEBD to anaphase onset) observed in response to
Plk1 inhibition showed a strong correlation with Mad2
levels. Furthermore, Tao1-NCB3 siRNA resulted in a more
s e v e r ed e p l e t i o no fM a d 2t h a nP I C H - 1s i R N Aa n d
(Fig. 10d), concomitantly, a more pronounced advancement
of mitotic timing (Fig. 10e), in excellent agreement with the
data shown above (Fig. 10a, b). Onthebasisofthese results,
we propose that restoration of SAC activity by depletion or
inhibition of Plk1 depends on residual levels of Mad2,
implying that depletion or inhibition of Plk1 enhances the
functionality of Mad2. In turn, these observations point to
the conclusion that—under physiological circumstances—
Plk1 antagonizes that SAC signaling function of Mad2.
Conclusions
Several conclusions emerge from this study. First and
foremost, our results question the previously reported
requirements for PICH (Baumann et al. 2007) and Tao1
(Draviam et al. 2007) for SAC activity. In the case of PICH,
we find it difficult to escape the conclusion that the previous
siRNA-based implication of this protein in the SAC reflects
an off-target effect on Mad2. At present, the precise
physiological function of PICH awaits further study, but
considering its conspicuous localization to centromeres,
KTs, and UFBs, a role in chromosome structure and
segregation appears likely. This view is supported by the
physical interaction between PICH and Plk1 and the
influence the two proteins exert on each other’s localization
(Baumann et al. 2007; Santamaria et al. 2007; Leng et al.
2008). Our study on Tao1 is less extensive, and some of our
results differ from those reported in the original study,
notably with regard to the effect of siRNA on Mad2 and the
advancement of mitotic timing (Draviam et al. 2007). Also,
we emphasize that Draviam and coworkers reported an
effective rescue of Tao1 depletion by active but not inactive
kinase (Draviam et al. 2007). Thus, further study will be
required to definitively validate or exclude a role for Tao1/
MARKK in the SAC. In any case, considering the role of
this kinase in the regulation of microtubules (Johne et al.
2008; Timm et al. 2003), an important contribution to
mitotic events is to be expected.
To our surprise, we discovered that Mad2 levels are
frequently reduced as a consequence of off-target effects
exerted by siRNA oligonucleotides. Considering that the
alignment of the Mad2 mRNA sequence with the sequences
of the various PICH- or Tao1-directed oligonucleotides
revealed no evidence for extensive complementarities
(Fig. 11 and data not shown), the Mad2 transcript is
unlikely to be the primary target of these siRNA duplexes.
Instead, we presume that the PICH-1, PICH-2, PICH-CC,
and Tao1-NCB3 duplexes target other transcripts, as yet
unidentified, which then affect Mad2 mRNA levels through
indirect mechanism(s). Microarray experiments and/or deep
sequencing will hopefully shed light on the target range of
these siRNA oligonucleotides. In turn, the identification of
critical targets may contribute to a better understanding
of the mechanisms that regulate Mad2 expression. From a
broader perspective, an important question is why Mad2
appears to be such a sensitive, albeit unintentional, target of
siRNA experiments. We see at least three plausible
explanations, which are not mutually exclusive. First,
although many proteins (including SAC components)
provide functionality even at reduced levels, this is clearly
not the case for Mad2, whose exact levels are critical for
function (Michel et al. 2001;H e r n a n d oe ta l .2004).
Therefore, even partial reductions in Mad2 levels are
expected to produce pronounced phenotypes. Second,
Mad2 plays a central role in SAC signaling and so its
expression is likely to be regulated by multiple mecha-
nisms. This in turn provides a broad range of transcripts and
pathways that could potentially be modulated by small
RNAs, perhaps including siRNAs that function as micro-
RNAs. Third, the loss of SAC activity that accompanies the
lowering of Mad2 levels is relatively easy to score in cellular
assays. Thus, a general prediction emerging from the present
study is that off-target effects will be identified more readily
if they converge onto proteins that are critically involved in
cellular processes that can easily be monitored.
Finally, our study illustrates that even rescue experi-
ments, the accepted “gold standard” for assessing siRNA
specificity, must be interpreted with caution, unless rescu-
ing proteins are re-expressed at physiological levels. In this
study, we have in fact discovered that the apparent “rescue”
of a siRNA phenotype depended on the ability of the
“rescuing” PICH protein to sequester the mitotic kinase
Plk1. This intriguing case of bypass suppression suggests
that Plk1 normally reduces the strength of the Mad2-
dependent inhibitory SAC signal. In future studies, it will
Chromosoma (2010) 119:149–165 161clearly be interesting to explore the molecular mechanism(s)
by which Plk1 affects SAC functionality.
Materials and methods
Cell lines
HeLa, U2OS, and HeLa cells stably expressing H2B–GFP
were grown under standard conditions in DMEM supple-
mented with 10% FBS and 1% penicillin/streptomycin. Cell
cycle synchronizations were performed by a single thymi-
dine (2 mM) block 10–12 h posttransfection with siRNA
duplexes. For microscopic analysis of mitotic cell cycle
stages, cells were released from thymidine for 12 h before
fixation. Mitotic cells were isolated by mitotic shake off.
The stable 293T TREX-shPICH cell lines were prepared
under selective conditions using blasticidin (5 µg/ml) and
puromycin (1 µg/ml) and grown under standard conditions.
Stable clones were picked and analyzed by Western blotting
and immunofluorescence microscopy before and after
tetracycline induction.
HeLa cells (pools) containing bacterial artificial chro-
mosomes (BACs) expressing C-terminally LAP-tagged
mouse PICH (Ercc6L, BAC-ID RP24-326A8) or mouse
Mad2L1 (BAC-ID RP23-84G11) were produced as de-
scribed previously (Poser et al. 2008). In brief, BACs were
obtained from the BACPAC Resources Center (http://
bacpac.chori.org), the LAP (EGFP-IRES-Neo)-cassette
was amplified by PCR using primers that carry homology
to the C terminus of Ercc6L and Mad2L1, respectively,
prior to transfection of the modified BAC.
Transfection of plasmids, siRNA, and plasmid
constructions
Plasmid and siRNA transfections were performed using
TransIT-LT1 transfection reagent (Mirus) and Oligofect-
amine reagent (Invitrogen), respectively, according to the
manufacturer’s instructions. The siRNA sequences of GL2
(Elbashir et al. 2001), Mad2, PICH-1, PICH-2 (Baumann et
al. 2007), PICH-CC (Leng et al. 2008), Tao1-NCB3
(Draviam et al. 2007), Aurora B (Klein et al. 2006),
Mps1, and Mad1 (Stucke et al. 2002) have been published
previously. The following siRNA target sequences were
purchased from Dharmacon (ON-TARGETplus) unless
otherwise stated: PICH-3: 3′-AGUAGGUGGUGUCGG
UUUA; PICH-4: 3′-GGAUAGAGUUUACC GAAUU;
PICH-5: 3′-CCAGAAACCUCAAUCGGAU; PICH-6: 3′-
ACUUUAAGACAUUGCGAAU; the PICH oligo
Alignment of Mad2 mRNA
and PICH siRNA oligonucleotides
Alignment of Mad2 mRNA
and Tao1 siRNA oligonucleotides 
Fig. 11 Alignment of PICH and Tao1 siRNA sequences with Mad2
mRNA. The alignments were performed using the global EMBOSS
pairwise Alignment Algorithm (http://www.ebi.ac.uk/Tools/emboss/
align) with a gap open of 50.0, and the Mad2 RNA accession number
NM_002358.3. The most extensive match observed for each oligonu-
cleotide is shown. Alignments colored in red or green refer to siRNA
duplexes that do or do not lower Mad2 transcripts, respectively
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PICH-5, and PICH-6 siRNAs; Tao1-2: 3′-CCAAGUAUCU
CGUCACAAA; Tao1-3: 3′-GUAAUAUGGUCCUUU
CUAA; Tao1-4: 3′-CUAAAGUGAUGUCCAAUGA;
Tao1-5: 3′-GCUGUGAGUUGAUCAGAUU; the Tao1
oligo SMART pool contained a mixture of Tao1-2, Tao1-
3, Tao1-4, and Tao1-5 siRNAs; Bub1: 3′-CCAGTGA
GTTCCTATCCAATT (Qiagen).
To clone PICH constructs for expression in HeLa cells,
PICH cDNA was amplified by PCR using pEGFP-C1-
PICH (WT and T1063A; Baumann et al. 2007)a sa
template and the following primers: M3863-
TCTCCCCGGGATGGAGGCATCCCGAAGGTTTC and
M3864-ATAAGAATGCGGCCGCTCAATTGT
TATTAAGTTGC. The Walker A mutant (K128A) was
generated by site-directed mutagenesis using the following
two oligonucleotides: M3821-GATGATATGGGATT
AGGGGCGACTGTTCAAATCATTGCT and M3822-
AGCAATGATTTGAACAGTCAGTCGCCCCTAAT
CCCATATCATC. For rescue experiments, mCherry-tagged
PICH constructs were used. The cDNA for mCherry was
PCR-amplified from pRSET-B-mCherry (a kind gift from
Roger Y Tsien), using the following primers: M3914-
CGGGGTACCGCCACCATGGTGAGCAAGGGCGA
GGAGGAT and M3915-GCGATATCCTTGTACA
GCTCGTCCATGCCG. The mCherry construct was then
subcloned into KpnI and EcoRV sites of the pcDNA4/TO
vector. Both WT and mutant PICH cDNAs were subcloned
into the pcDNA4/TO-mCherry vector. To make constructs
resistant against PICH-1 siRNA (Baumann et al. 2007), the
above constructs were then subjected to site-directed
mutagenesis using the following primers: M3344-
GAGGGTGAGAAACAAGACTTATCCAGTATA
AAGGTG and M3345-CACCTTTATACTGGATAA
GTCTTGTTTCTCACCCTC. For construction of the
shPICH plasmid, the following oligonucleotides were
annealed in annealing buffer (200 mM Tris pH 7.5,
100 mM MgCl2 and 500 mM NaCl) for 1 h at 37°C and
cloned into pTER +vector using BglII and HindIII
restriction sites: M3666-GATCCCCAAGATCTCTCCAG
TATA TTCAAGAGATTATACTGGAGAGATCTTGTT
TTTGGAAA and M3667-AGCTTTTCCAAAAACAA
GATCTCTCCAGTATAATCTCTTGAATTATACTGGAGA
GATCTTGGG. (Italic letters indicate the siRNA sequence
published for siPICH-1 (Baumann et al. 2007)). Full-length
Mad2 was amplified by PCR and subcloned into pEGFP-
C2 through BamH1 and Sal1 restriction sites. All constructs
were verified by sequencing.
Live-cell imaging
For imaging experiments, HeLa cells stably expressing
histone H2B–GFP were used (Sillje et al. 2006). They were
cultured in eight-well chamber slides (Ibidi) with 300 μl
medium per well and transfected with siRNA oligonucleo-
tides and/or plasmid constructs, as appropriate. Ten hours
posttransfection, they were synchronized using 2 mM
thymidine for 24 h and then released into fresh medium
for 8 h prior to imaging. Live-cell imaging was performed
using a Zeiss Axiovert 2 microscope equipped with a Plan
Neofluar 20x1.6 optivar/NA=0.75 objective, an environmen-
tal chamber, and a CoolSNAP-ES2 digital camera system.
Movieswereacquiredoveratleast 12h,withpicturestakenat
time intervals of 3 min. Images were captured with 2.5–5m s
exposure time for histone H2B–GFP, 30 ms for mCherry and
50 ms for DIC. Metaview software (Visitron Systems) was
used for data collection and analysis.
Western blotting
Whole cell extracts were prepared using lysis buffer (20 mM
Tris/HCl pH7.4, 150 mM NaCl, 40 mM β-glycerophosphate,
10 mM NaF, 0.5% IGEPAL, 2 mM Pefabloc (Roth), 0.3 mM
NaVO3, 100 µM ATP, 100 µM MgCl2, 100 nM okadaic
acid, one protease inhibitor tablet per 10 ml lysis buffer
(Roche)). Proteins were resolved by sodium dodecyl sulfate
(SDS)–polyacrylamide gel electrophoresis and transferred to
polyvinylidene fluoride membranes (Millipore), and these
were probed with primary antibodies overnight at 4°C.
Membranes were washed with 0.5% Tween/phosphate-
buffered saline (PBS) before incubation with secondary
antibodies. Antibodies used were rabbit anti-Mad2 (Bethyl),
rabbit anti-Tao1 (Bethyl), rabbit anti-PICH (Baumann et al.
2007), monoclonal anti-α-Tubulin (DM1A, Sigma), mouse
anti-Mad1 (Sigma), mouse anti-Aurora B (AIM1; BD
Transduction), monoclonal anti-Mps1 (Stucke et al. 2002).
Monoclonal anti-Bub1 and monoclonal anti-GFP antibodies
were kindly provided by Andreas Uldschmidt.
Immunofluorescence microscopy
Cellsweregrownoncoverslips,fixedwithPTEMFfor10min
at room temperature (Stucke et al. 2002), and incubated for
20 min at room temperature in 3% bovine serum albumin/
PBS. Antibody incubations were carried out for 1 h at room
temperature, followed by three washes in 0.5% TritonX-100/
PBS. DNA was stained with 1 µg/ml 4,6-diamidino-2-
phenylindole (DAPI). For image acquisition, a Deltavision
microscope (Applied Precision) on a Nikon Eclipse TE200
base (Applied Precision) equipped with an Apo 60/1.4 oil
immersion objective and a CoolSnap HQ camera (Photo-
metrics) was used. Samples were examined with optical
sections acquired 0.4 µm apart in the z-axis, deconvolved for
each focal plane and projected into a single-plane image
using the Softworx software (Applied Precision). For
immunostaining, rabbit anti-Mad2 (Bethyl), rat anti-PICH
Chromosoma (2010) 119:149–165 163(Baumann et al. 2007), and mouse anti-Aurora B (AIM1;
BD Transduction) were used. Primary antibodies were
detected by Cy3-conjugated donkey antibodies (Dianova)
andAlexa-Fluor-647-conjugatedgoatantibodies(Invitrogen).
Quantitative real-time PCR
To monitor mRNA levels, HeLa cells were depleted of
various proteins by siRNA and synchronized by a single
thymidine block. To analyze the expression levels of Mad1,
Mad2, PICH, and Tao1 transcripts, total RNAwas extracted
using an RNeasy Mini kit according to manufacturer’s
protocol (Qiagen) and quality-controlled for integrity by
capillary electrophoresis on Agilent 2100 Bioanalyzer.
Transcript levels were determined by qRT-PCR. First-
strand cDNA synthesis was carried out from 1 µg of total
RNA by using SuperScript II Reverse Transcriptase and
random primers following the manufacturer’s instructions
(Invitrogen Life Technologies). The amplicons were
designed with the program Primer Express 2.0 (Applied
Biosystems, Foster City, CA, USA) by using default
parameters such that they spanned exon boundaries. Primer
sequences are available upon request. Amplicon sequences
where checked by BLAST against the human genome to
ensure that they were specific for the gene being assayed.
The specificity of each primer pair as well as the efficiency
of the amplification step was tested by assaying serial
dilutions of cDNA. PCR reactions were carried out in
triplicate by using an SDS 7900 HT instrument (Applied
Biosystems) and Power SYBR Green PCR master mix kits
(Applied Biosystems). Normalization genes were selected
using the geNorm script as published (Vandesompele et al.
2002). Raw Ct values obtained with SDS 2.0 (Applied
Biosystems) were imported into Excel (Microsoft, Redmond,
WA, USA) to calculate the normalization factor and the fold
changes with the geNorm (Vandesompele et al. 2002).
Acknowledgements We thank Roger Tsien and Andreas Uldschmid
for reagents, Christelle Barraclough for help with qRT-PCR, and
Rainer Malik for help with bioinformatics. We also thank Christoph
Baumann, Viji Draviam, Steve Elledge, and all members of the Nigg lab
for helpful discussions. This work was supported by the Max-Planck-
Society. L.H. W. acknowledges a fellowship from the Taiwan Merit
Scholarships program (NSC-095-SAF-I-564-627-TMS). NCH gratefully
acknowledges the Ph.D. fellowship from the Boehringer Ingelheim Fonds.
Open Access This article is distributed under the terms of the Creative
Commons Attribution Noncommercial License which permits any
noncommercial use, distribution, and reproduction in any medium,
provided the original author(s) and source are credited.
References
Bachrati CZ, Hickson ID (2008) RecQ helicases: guardian angels of
the DNA replication fork. Chromosoma 117(3):219–233
Baumann C, Korner R, Hofmann K, Nigg EA (2007) PICH, a
centromere-associated SNF2 family ATPase, is regulated by Plk1
and required for the spindle checkpoint. Cell 128(1):101–114
Chan KL, North PS, Hickson ID (2007) BLM is required for faithful
chromosome segregation and its localization defines a class of
ultrafine anaphase bridges. Embo J 26(14):3397–3409
Chan KL, Palmai-Pallag T, Ying S, Hickson ID (2009) Replication
stress induces sister-chromatid bridging at fragile site loci in
mitosis. Nat Cell Biol 11(6):753–760
Ditchfield C, Johnson VL, Tighe A, Ellston R, Haworth C,
Johnson T, Mortlock A, Keen N, Taylor SS (2003) Aurora B
couples chromosome alignment with anaphase by targeting
BubR1, Mad2, and Cenp-E to kinetochores. J Cell Biol 161
(2):267–280
Draviam VM, Stegmeier F, Nalepa G, Sowa ME, Chen J, Liang A,
Hannon GJ, Sorger PK, Harper JW, Elledge SJ (2007) A
functional genomic screen identifies a role for TAO1 kinase in
spindle-checkpoint signalling. Nat Cell Biol 9(5):556–564
Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T
(2001) Duplexes of 21-nucleotide RNAs mediate RNA interfer-
ence in cultured mammalian cells. Nature 411(6836):494–498
Hauf S, Waizenegger IC, Peters JM (2001) Cohesin cleavage by
separase required for anaphase and cytokinesis in human cells.
Science 293(5533):1320–1323
Hernando E, Nahle Z, Juan G, Diaz-Rodriguez E, Alaminos M,
Hemann M, Michel L, Mittal V, Gerald W, Benezra R, Lowe SW,
Cordon-Cardo C (2004) Rb inactivation promotes genomic
instability by uncoupling cell cycle progression from mitotic
control. Nature 430(7001):797–802
Johne C, Matenia D, Li XY, Timm T, Balusamy K, Mandelkow EM
(2008) Spred1 and TESK1—two new interaction partners of the
kinase MARKK/TAO1 that link the microtubule and actin
cytoskeleton. Mol Biol Cell 19(4):1391–1403
Klein UR, Nigg EA, Gruneberg U (2006) Centromere targeting of the
chromosomal passenger complex requires a ternary subcomplex
of borealin, survivin, and the N-terminal domain of INCENP.
Mol Biol Cell 17(6):2547–2558
Leng M, Bessuso D, Jung SY, Wang Y, Qin J (2008) Targeting Plk1 to
chromosome arms and regulating chromosome compaction by
the PICH ATPase. Cell Cycle 7(10):1480–1489
Liu X, Erikson RL (2003) Polo-like kinase (Plk)1 depletion induces
apoptosis in cancer cells. Proc Natl Acad Sci U S A 100
(10):5789–5794
Michel LS, Liberal V, Chatterjee A, Kirchwegger R, Pasche B,
Gerald W, Dobles M, Sorger PK, Murty VV, Benezra R
(2001) MAD2 haplo-insufficiency causes premature anaphase
and chromosome instability in mammalian cells. Nature 409
(6818):355–359
Naim V, Rosselli F (2009) The FANC pathway and BLM collaborate
during mitosis to prevent micro-nucleation and chromosome
abnormalities. Nat Cell Biol 11(6):761–768
Petronczki M, Lenart P, Peters JM (2008) Polo on the rise—from
mitotic entry to cytokinesis with Plk1. Dev Cell 14(5):646–659
Poser I, Sarov M, Hutchins JR, Heriche JK, Toyoda Y, Pozniakovsky
A, Weigl D, Nitzsche A, Hegemann B, Bird AW, Pelletier L,
Kittler R, Hua S, Naumann R, Augsburg M, Sykora MM,
Hofemeister H, Zhang Y, Nasmyth K, White KP, Dietzel S,
Mechtler K, Durbin R, Stewart AF, Peters JM, Buchholz F,
Hyman AA (2008) BAC TransgeneOmics: a high-throughput
method for exploration of protein function in mammals. Nat
Methods 5(5):409–415
Santamaria A, Neef R, Eberspacher U, Eis K, Husemann M,
Mumberg D, Prechtl S, Schulze V, Siemeister G, Wortmann L,
Barr FA, Nigg EA (2007) Use of the novel Plk1 inhibitor ZK-
thiazolidinone to elucidate functions of Plk1 in early and late
stages of mitosis. Mol Biol Cell 18(10):4024–4036
164 Chromosoma (2010) 119:149–165Sillje HH, Nagel S, Korner R, Nigg EA (2006) HURP is a Ran-
importin beta-regulated protein that stabilizes kinetochore micro-
tubules in the vicinity of chromosomes. Curr Biol 16(8):731–742
Stucke VM, Sillje HH, Arnaud L, Nigg EA (2002) Human Mps1
kinase is required for the spindle assembly checkpoint but not for
centrosome duplication. Embo J 21(7):1723–1732
Timm T, Li XY, Biernat J, Jiao J, Mandelkow E, Vandekerckhove J,
Mandelkow EM (2003) MARKK, a Ste20-like kinase, activates the
polarity-inducingkinaseMARK/PAR-1.EmboJ22(19):5090–5101
Uhlmann F, Lottspeich F, Nasmyth K (1999) Sister-chromatid
separation at anaphase onset is promoted by cleavage of the
cohesin subunit Scc1. Nature 400(6739):37–42
Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N,
De Paepe A, Speleman F (2002) Accurate normalization of
real-time quantitative RT-PCR data by geometric averaging
of multiple internal control genes. Genome Biol 3(7):
RESEARCH0034
Vigneron S, Prieto S, Bernis C, Labbe JC, Castro A, Lorca T (2004)
Kinetochore localization of spindle checkpoint proteins: who
controls whom? Mol Biol Cell 15(10):4584–4596
Wang LH, Schwarzbraun T, Speicher MR, Nigg EA (2008)
Persistence of DNA threads in human anaphase cells suggests
late completion of sister chromatid decatenation. Chromosoma
117(2):123–135
Chromosoma (2010) 119:149–165 165